newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company will participate in upcoming